These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19954345)

  • 1. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish.
    Dovey M; White RM; Zon LI
    Zebrafish; 2009 Dec; 6(4):397-404. PubMed ID: 19954345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural crest state activation in NRAS driven melanoma, but not in NRAS-driven melanocyte expansion.
    McConnell AM; Mito JK; Ablain J; Dang M; Formichella L; Fisher DE; Zon LI
    Dev Biol; 2019 May; 449(2):107-114. PubMed ID: 29883661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish.
    Santoriello C; Gennaro E; Anelli V; Distel M; Kelly A; Köster RW; Hurlstone A; Mione M
    PLoS One; 2010 Dec; 5(12):e15170. PubMed ID: 21170325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIT Suppresses BRAF
    Neiswender JV; Kortum RL; Bourque C; Kasheta M; Zon LI; Morrison DK; Ceol CJ
    Cancer Res; 2017 Nov; 77(21):5820-5830. PubMed ID: 28947418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models.
    Yen J; White RM; Wedge DC; Van Loo P; de Ridder J; Capper A; Richardson J; Jones D; Raine K; Watson IR; Wu CJ; Cheng J; Martincorena I; Nik-Zainal S; Mudie L; Moreau Y; Marshall J; Ramakrishna M; Tarpey P; Shlien A; Whitmore I; Gamble S; Latimer C; Langdon E; Kaufman C; Dovey M; Taylor A; Menzies A; McLaren S; O'Meara S; Butler A; Teague J; Lister J; Chin L; Campbell P; Adams DJ; Zon LI; Patton EE; Stemple DL; Futreal PA
    Genome Biol; 2013; 14(10):R113. PubMed ID: 24148783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting Oncogenic RAS Signaling in Melanoma Development in Genetically Engineered Zebrafish Models.
    Badrock AP; Hurlstone A
    Methods Mol Biol; 2021; 2262():411-422. PubMed ID: 33977492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRAS
    Banik I; Cheng PF; Dooley CM; Travnickova J; Merteroglu M; Dummer R; Patton EE; Busch-Nentwich EM; Levesque MP
    Pigment Cell Melanoma Res; 2021 Mar; 34(2):150-162. PubMed ID: 32910840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas.
    Chagani S; Wang R; Carpenter EL; Löhr CV; Ganguli-Indra G; Indra AK
    BMC Cancer; 2017 Nov; 17(1):736. PubMed ID: 29121869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment.
    Coleman DJ; Chagani S; Hyter S; Sherman AM; Löhr CV; Liang X; Ganguli-Indra G; Indra AK
    Mol Cancer Res; 2015 Jan; 13(1):186-96. PubMed ID: 25189354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro.
    Eskandarpour M; Huang F; Reeves KA; Clark E; Hansson J
    Int J Cancer; 2009 Jan; 124(1):16-26. PubMed ID: 18814281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global repression of cancer gene expression in a zebrafish model of melanoma is linked to epigenetic regulation.
    Anelli V; Santoriello C; Distel M; Köster RW; Ciccarelli FD; Mione M
    Zebrafish; 2009 Dec; 6(4):417-24. PubMed ID: 20047469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-146a promotes the initiation and progression of melanoma by activating Notch signaling.
    Forloni M; Dogra SK; Dong Y; Conte D; Ou J; Zhu LJ; Deng A; Mahalingam M; Green MR; Wajapeyee N
    Elife; 2014 Feb; 3():e01460. PubMed ID: 24550252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.
    Patton EE; Widlund HR; Kutok JL; Kopani KR; Amatruda JF; Murphey RD; Berghmans S; Mayhall EA; Traver D; Fletcher CD; Aster JC; Granter SR; Look AT; Lee C; Fisher DE; Zon LI
    Curr Biol; 2005 Feb; 15(3):249-54. PubMed ID: 15694309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
    Yu H; McDaid R; Lee J; Possik P; Li L; Kumar SM; Elder DE; Van Belle P; Gimotty P; Guerra M; Hammond R; Nathanson KL; Dalla Palma M; Herlyn M; Xu X
    Am J Pathol; 2009 Jun; 174(6):2367-77. PubMed ID: 19389934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
    Lázár V
    Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.
    Feng Y; Lau E; Scortegagna M; Ruller C; De SK; Barile E; Krajewski S; Aza-Blanc P; Williams R; Pinkerton AB; Jackson M; Chin L; Pellecchia M; Bosenberg M; Ronai ZA
    Pigment Cell Melanoma Res; 2013 Jan; 26(1):136-42. PubMed ID: 23035722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors.
    Ki DH; He S; Rodig S; Look AT
    Oncogene; 2017 Feb; 36(8):1058-1068. PubMed ID: 27477693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.